We have previously shown that TLR9-triggering by ODN CpG 2006 or Hemozoin inhibits EBV lytic reactivation, i.e. expression of BZLF1, induced by BCR cross-linking in BL cells in vitro [26]. This evidence concerns the gene BCR and Burkitt lymphoma.